Startups

GlycanAge
Develops blood-based glycan biomarker tests for assessing biological age and chronic inflammation. Its technology analyzes sugar structures attached to immunoglobulin G proteins and translates the results into reports for individuals, clinicians and researchers. The company is expanding clinical validation and diagnostic applications for preventive healthcare.
Founded 2020